Get started
Author

Ziming Li

The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis
2014 · Shun Lu, Ding Ding, et al. · OncoTargets and Therapy · 40
PDF
Interferon-γ-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer
2025 · Zhengqi Cao, Zhouwenli Meng, et al. · Cell Reports Medicine · 30
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer
2024 · Isamu Okamoto, Shoichi Kuyama, et al. · Future Oncology · 21
PTPRT loss enhances anti–PD-1 therapy efficacy by regulation of STING pathway in non–small cell lung cancer
2024 · Zhuo Chen, Wenxiang Ji, et al. · Science Translational Medicine · 21
Single-cell low-pass whole genome sequencing accurately detects circulating tumor cells for liquid biopsy-based multi-cancer diagnosis
2024 · Xiaohan Shen, Jiao Dai, et al. · npj Precision Oncology · 21
PDF
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
2024 · Wenxian Wang, Bin Lian, et al. · The Innovation · 14
Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study
2025 · Christos Chouaid, Lise Bosquet, et al. · Lung Cancer · 4
Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small-cell lung cancer
2026 · Zhuo Wang, Qing Luo, et al. · Cell Reports Medicine · 3
Oral administration of osimertinib mesylate induced multiple peripheral neuropathy of a non-small-cell lung cancer patient and treated with traditional Chinese medicine - A case report
2025 · Xiange Huang, Hegen Li, et al. · Journal of Ayurveda and Integrative Medicine · 1
Abstract 3770: DNA methylation-based model predicts occult lymph nodal metastasis for resectable NSCLC patients
2026 · Long Jiang, Xing Li, et al. · Cancer Research
Abstract 6317: A reference-free PCR assay for absolute quantification of cancer methylation biomarkers
2026 · Ziming Li, Huichuan Yu · Cancer Research
Expert consensus on the detection and clinical application of tumor mutational burden
2026 · Zhenying Guo, Chunwei Xu, et al. · Cancer Biology and Medicine
DTCFinder: a bench-to-bits toolkit for label-free, whole-spectrum analysis of disseminated and circulating tumor cells in liquid biopsies
2025 · Xiaowei Yan, Zhuo Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
TuCCL: Tailored and Unified Configuration Optimizations for High-Performance Collective Communication Library
2025 · Ziming Li, Chenyang Hei, et al. · Proceedings/Proceedings - International Conference on Network Protocols
Clinical benefit evaluation of drug treatment regimens for advanced lung cancer:based on ASCO-VF and ESMO-MCBS
2024 · Jingdan Pang, Yiruo Zhang, et al. · Lung Cancer
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non–Small-Cell Lung Cancer?
2023 · Ziming Li, Shun Lu · Journal of Clinical Oncology
PDF
Works count: 16
Citation count: 154
H-index: 6
I10-index: 6
Year
Topic
Type